ImmunologybioRxivPreprint
Highly potent anti-SARS-CoV-2 multivalent DARPin therapeutic candidates
M. Walser, S. Rothenberger, D. L. Hurdiss…·Stittela
This paper develops potent anti-SARS-CoV-2 DARPin therapeutics with low picomolar neutralization efficacy and reports their protective efficacy in a hamster model.
DOI 10.1101/2020.08.25.256339